Union procedures for the authorisation and supervision of medicinal products for human use and rules governing the European Medicines Agency

Key: ✓ For ✗ Against ○ Abstained ÷ Divided (no clear line)

Nobody voted against a clear line of their group.

589 members with a recorded position.

Roll calls requested by The Left, ID · split votes by ECR (5) · separate votes by ECR.

Report A-9-2024-0141

2023/0131(COD) · Ordinary legislative procedure

Laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency, amending Regulation (EC) No 1394/2007 and Regulation (EU) No 536/2014 and repealing Regulation (EC) No 726/2004, Regulation (EC) No 141/2000 and Regulation (EC) No 1901/2006

Parliament’s committee approved the deal reached with the Council on 18 March 2026; the plenary vote on it is still to come.

Lead committee: ENVI · Rapporteur: Tiemo WÖLKEN (S&D)

No connections found for this decision.

Permalink

https://news.eu-parl.st-solutions.dev/decisions/2024-04-10/32?members=all

Official sources

• Roll-call votes, sitting of 10 April 2024 (European Parliament) ↗
• Results of votes, sitting of 10 April 2024 (European Parliament) ↗

Data source

• EP Open Data API: decisions of the sitting MTG-PL-2024-04-10 ↗

Licensed CC BY 4.0.

Retrieved

25 September 2026

European Parliament (2024). “Union procedures for the authorisation and supervision of medicinal products for human use and rules governing the European Medicines Agency”. Decision, 10 April 2024. votingId 166879, document A-9-2024-0141, reference 2023-0131. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/decisions/2024-04-10/32?members=all (retrieved 25 September 2026). Official sources: Roll-call votes, sitting of 10 April 2024 (European Parliament), https://www.europarl.europa.eu/doceo/document/PV-10-2024-04-10-RCV_EN.html; Results of votes, sitting of 10 April 2024 (European Parliament), https://www.europarl.europa.eu/doceo/document/PV-10-2024-04-10-VOT_EN.html. Data: EP Open Data API: decisions of the sitting MTG-PL-2024-04-10, https://data.europarl.europa.eu/api/v2/meetings/MTG-PL-2024-04-10/decisions?format=application%2Fld%2Bjson (CC BY 4.0).

@misc{epw-decision-2024-04-10-32,
  author = {{European Parliament}},
  title = {{Union procedures for the authorisation and supervision of medicinal products for human use and rules governing the European Medicines Agency}},
  year = {2024},
  date = {2024-04-10},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/decisions/2024-04-10/32?members=all}},
  url = {https://news.eu-parl.st-solutions.dev/decisions/2024-04-10/32?members=all},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Decision. votingId 166879, document A-9-2024-0141, reference 2023-0131. Official source: https://www.europarl.europa.eu/doceo/document/PV-10-2024-04-10-RCV\_EN.html, https://www.europarl.europa.eu/doceo/document/PV-10-2024-04-10-VOT\_EN.html. Data: EP Open Data API: decisions of the sitting MTG-PL-2024-04-10 (CC BY 4.0)}
}